Autor: "Ambros PF" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Amplification of CDK4 and MDM2: a detailed study of a high-risk neuroblastoma subgroup.
Autorzy:: Martinez-Monleon A; Department of Laboratory Medicine, University of Gothenburg, Box 445, 405 30, Gothenburg, Sweden.
Kryh Öberg H; Department of Laboratory Medicine, University of Gothenburg, Box 445, 405 30, Gothenburg, Sweden.
Gaarder J; Department of Laboratory Medicine, University of Gothenburg, Box 445, 405 30, Gothenburg, Sweden.
Berbegall AP; Department of Pathology, Faculty of Medicine and Dentistry, University of Valencia, Valencia, Spain.
Javanmardi N; Department of Laboratory Medicine, University of Gothenburg, Box 445, 405 30, Gothenburg, Sweden.
Djos A; Department of Laboratory Medicine, University of Gothenburg, Box 445, 405 30, Gothenburg, Sweden.
Ussowicz M; Department of Pediatric Bone Marrow Transplantation, Oncology and Hematology, Wroclaw Medical University, 50-556, Wrocław, Poland.
Taschner-Mandl S; St. Anna Children's Cancer Research Institute (CCRI), Vienna, Austria.
Ambros IM; St. Anna Children's Cancer Research Institute (CCRI), Vienna, Austria.
Øra I; Department of Pediatric Oncology and Hematology, Clinical Sciences, Lund University, Lund, Sweden.
Sandstedt B; Childhood Cancer Research Unit, Karolinska Institutet, Stockholm, Sweden.
Beiske K; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Ladenstein R; St. Anna Children's Cancer Research Institute (CCRI), Vienna, Austria.
Noguera R; Department of Pathology, Faculty of Medicine and Dentistry, University of Valencia, Valencia, Spain.
Ambros PF; St. Anna Children's Cancer Research Institute (CCRI), Vienna, Austria.
Gordon Murkes L; Department of Pediatric Radiology, Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden.
Ljungman G; Department of Women's and Children's Health, Children's University Hospital, University of Uppsala, Uppsala, Sweden.
Kogner P; Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.
Fransson S; Department of Laboratory Medicine, University of Gothenburg, Box 445, 405 30, Gothenburg, Sweden. .
Martinsson T; Department of Laboratory Medicine, University of Gothenburg, Box 445, 405 30, Gothenburg, Sweden.; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2022 Jul 20; Vol. 12 (1), pp. 12420. Date of Electronic Publication: 2022 Jul 20.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Neuroblastoma*/pathology
Proto-Oncogene Proteins c-mdm2*/genetics
Proto-Oncogene Proteins c-mdm2*/metabolism
Cyclin-Dependent Kinase 4/genetics ; Cyclin-Dependent Kinase 4/metabolism ; Gene Amplification ; Humans ; Prognosis ; Tumor Suppressor Protein p53/genetics ; Tumor Suppressor Protein p53/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Landscape of Bone Marrow Metastasis in Human Neuroblastoma Unraveled by Transcriptomics and Deep Multiplex Imaging.
Autorzy:: Lazic D; St. Anna Children's Cancer Research Institute (CCRI), 1090 Vienna, Austria.
Kromp F; St. Anna Children's Cancer Research Institute (CCRI), 1090 Vienna, Austria.; Software Competence Center Hagenberg (SCCH), 4232 Hagenberg, Austria.
Rifatbegovic F; St. Anna Children's Cancer Research Institute (CCRI), 1090 Vienna, Austria.
Repiscak P; St. Anna Children's Cancer Research Institute (CCRI), 1090 Vienna, Austria.
Kirr M; Department of Dermatology, University Hospital Erlangen, 91054 Erlangen, Germany.
Mivalt F; St. Anna Children's Cancer Research Institute (CCRI), 1090 Vienna, Austria.
Halbritter F; St. Anna Children's Cancer Research Institute (CCRI), 1090 Vienna, Austria.
Bernkopf M; St. Anna Children's Cancer Research Institute (CCRI), 1090 Vienna, Austria.
Bileck A; Department of Analytical Chemistry, Faculty of Chemistry, University of Vienna, 1090 Vienna, Austria.
Ussowicz M; Department and Clinic of Pediatric Oncology, Hematology and Bone Marrow, Transplantation, Wroclaw Medical University, 50-556 Wroclaw, Poland.
Ambros IM; St. Anna Children's Cancer Research Institute (CCRI), 1090 Vienna, Austria.
Ambros PF; St. Anna Children's Cancer Research Institute (CCRI), 1090 Vienna, Austria.
Gerner C; Department of Analytical Chemistry, Faculty of Chemistry, University of Vienna, 1090 Vienna, Austria.
Ladenstein R; St. Anna Children's Cancer Research Institute (CCRI), 1090 Vienna, Austria.
Ostalecki C; Department of Dermatology, University Hospital Erlangen, 91054 Erlangen, Germany.
Taschner-Mandl S; St. Anna Children's Cancer Research Institute (CCRI), 1090 Vienna, Austria.; Pokaż więcej
Źródło:: Cancers [Cancers (Basel)] 2021 Aug 26; Vol. 13 (17). Date of Electronic Publication: 2021 Aug 26.
Typ publikacji:: Journal Article

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Long-Term Outcome and Role of Biology within Risk-Adapted Treatment Strategies: The Austrian Neuroblastoma Trial A-NB94.
Autorzy:: Fiedler S; St. Anna Children's Hospital, 1090 Vienna, Austria.; CCRI, Children's Cancer Research Institute, 1090 Vienna, Austria.
Ambros IM; CCRI, Children's Cancer Research Institute, 1090 Vienna, Austria.
Glogova E; CCRI, Children's Cancer Research Institute, 1090 Vienna, Austria.
Benesch M; Department of Pediatrics and Adolescent Medicine, Division of Pediatric Hematology and Oncology, Medical University of Graz, 8036 Graz, Austria.
Urban C; Department of Pediatrics and Adolescent Medicine, Division of Pediatric Hematology and Oncology, Medical University of Graz, 8036 Graz, Austria.
Mayer M; Department of Pediatrics and Adolescent Medicine, Division of Pediatric Hematology and Oncology, Medical University of Graz, 8036 Graz, Austria.
Ebetsberger-Dachs G; Med Campus IV, University Clinic for Pediatrics, Kepler University Hospital, 4020 Linz, Austria.
Bardi E; St. Anna Children's Hospital, 1090 Vienna, Austria.; Med Campus IV, University Clinic for Pediatrics, Kepler University Hospital, 4020 Linz, Austria.
Jones N; Department of Pediatrics, Paracelsus Medical University, 5020 Salzburg, Austria.
Gamper A; Department of Pediatrics, Paracelsus Medical University, 5020 Salzburg, Austria.
Meister B; Department of Pediatric Hematology, Oncology, and Stem-Cell Transplantation, Medical University of Innsbruck, 6020 Innsbruck, Austria.
Crazzolara R; Department of Pediatric Hematology, Oncology, and Stem-Cell Transplantation, Medical University of Innsbruck, 6020 Innsbruck, Austria.
Amann G; Department of Pathology, Medical University of Vienna, 1090 Vienna, Austria.
Dieckmann K; Department of Radiotherapy, Medical University of Vienna, 1090 Vienna, Austria.
Horcher E; Department of Pediatric Surgery, Medical University of Vienna, 1090 Vienna, Austria.
Kerbl R; Department of Pediatric Medicine, Landeskrankenhaus Leoben, 8700 Leoben, Austria.
Brunner-Herglotz B; CCRI, Children's Cancer Research Institute, 1090 Vienna, Austria.
Ziegler A; CCRI, Children's Cancer Research Institute, 1090 Vienna, Austria.
Ambros PF; CCRI, Children's Cancer Research Institute, 1090 Vienna, Austria.
Ladenstein R; St. Anna Children's Hospital, 1090 Vienna, Austria.; CCRI, Children's Cancer Research Institute, 1090 Vienna, Austria.; Department of Pediatric Medicine, Medical University of Vienna, 1090 Vienna, Austria.; Pokaż więcej
Źródło:: Cancers [Cancers (Basel)] 2021 Feb 02; Vol. 13 (3). Date of Electronic Publication: 2021 Feb 02.
Typ publikacji:: Journal Article

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Tumor Touch Imprints as Source for Whole Genome Analysis of Neuroblastoma Tumors.
Autorzy:: Brunner C; Department of Tumor Biology, CCRI, Children's Cancer Research Institute, St. Anna Kinderkrebsforschung, Vienna, Austria.
Brunner-Herglotz B; Department of Tumor Biology, CCRI, Children's Cancer Research Institute, St. Anna Kinderkrebsforschung, Vienna, Austria.
Ziegler A; Department of Tumor Biology, CCRI, Children's Cancer Research Institute, St. Anna Kinderkrebsforschung, Vienna, Austria.
Frech C; Department of Tumor Biology, CCRI, Children's Cancer Research Institute, St. Anna Kinderkrebsforschung, Vienna, Austria.
Amann G; Institute of Clinical Pathology, Medical University Vienna, Vienna, Austria.
Ladenstein R; S2IRP, CCRI, Children's Cancer Research Institute, St. Anna Kinderkrebsforschung, Vienna, Austria.; Department of Pediatrics, Medical University Vienna, Vienna, Austria.
Ambros IM; Department of Tumor Biology, CCRI, Children's Cancer Research Institute, St. Anna Kinderkrebsforschung, Vienna, Austria.
Ambros PF; Department of Tumor Biology, CCRI, Children's Cancer Research Institute, St. Anna Kinderkrebsforschung, Vienna, Austria.; Department of Pediatrics, Medical University Vienna, Vienna, Austria.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2016 Aug 25; Vol. 11 (8), pp. e0161369. Date of Electronic Publication: 2016 Aug 25 (Print Publication: 2016).
Typ publikacji:: Journal Article
MeSH Terms:: In Situ Hybridization, Fluorescence*
Neoplasms/*diagnosis
Neoplasms/*genetics
Neuroblastoma/*diagnosis
Neuroblastoma/*genetics
Biomarkers, Tumor/genetics ; Chromosome Aberrations ; Computational Biology ; DNA, Neoplasm/genetics ; Feasibility Studies ; Genome, Human ; Humans ; Loss of Heterozygosity ; Oligonucleotide Array Sequence Analysis ; Polymorphism, Single Nucleotide ; Signal Processing, Computer-Assisted

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Chromosome 1q gain and tenascin-C expression are candidate markers to define different risk groups in pediatric posterior fossa ependymoma.
Autorzy:: Araki A; Institute of Neurology, Medical University of Vienna, Vienna, Austria.; Comprehensive Cancer Center, Medical University of Vienna, Währinger Gürtel 18-20, A-1097, Vienna, Austria.; Children's Cancer Research Institute, Vienna, Austria.; Present address: Organ Pathology Unit, School of Medicine, Shimane University, Izumo, Japan.
Chocholous M; Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria.; Comprehensive Cancer Center, Medical University of Vienna, Währinger Gürtel 18-20, A-1097, Vienna, Austria.
Gojo J; Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria.; Comprehensive Cancer Center, Medical University of Vienna, Währinger Gürtel 18-20, A-1097, Vienna, Austria.
Dorfer C; Department of Neurosurgery, Medical University of Vienna, Vienna, Austria.; Comprehensive Cancer Center, Medical University of Vienna, Währinger Gürtel 18-20, A-1097, Vienna, Austria.
Czech T; Department of Neurosurgery, Medical University of Vienna, Vienna, Austria.; Comprehensive Cancer Center, Medical University of Vienna, Währinger Gürtel 18-20, A-1097, Vienna, Austria.
Heinzl H; Center for Medical Statistics, Informatics, and Intelligent Systems, Medical University of Vienna, Vienna, Austria.
Dieckmann K; Department of Radiotherapy, Medical University of Vienna, Vienna, Austria.; Comprehensive Cancer Center, Medical University of Vienna, Währinger Gürtel 18-20, A-1097, Vienna, Austria.
Ambros IM; Children's Cancer Research Institute, Vienna, Austria.
Ambros PF; Children's Cancer Research Institute, Vienna, Austria.
Slavc I; Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria.; Comprehensive Cancer Center, Medical University of Vienna, Währinger Gürtel 18-20, A-1097, Vienna, Austria.
Haberler C; Institute of Neurology, Medical University of Vienna, Vienna, Austria. .; Comprehensive Cancer Center, Medical University of Vienna, Währinger Gürtel 18-20, A-1097, Vienna, Austria. .; Pokaż więcej
Źródło:: Acta neuropathologica communications [Acta Neuropathol Commun] 2016 Aug 22; Vol. 4 (1), pp. 88. Date of Electronic Publication: 2016 Aug 22.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Chromosomes, Human, Pair 1*
Ependymoma/*genetics
Ependymoma/*metabolism
Infratentorial Neoplasms/*genetics
Infratentorial Neoplasms/*metabolism
Tenascin/*metabolism
Adolescent ; Age Factors ; Biomarkers, Tumor/genetics ; Biomarkers, Tumor/metabolism ; Child ; Child, Preschool ; Chromosome Duplication ; Ependymoma/classification ; Ependymoma/pathology ; Female ; Gene Expression Regulation, Neoplastic ; Genetic Predisposition to Disease ; Humans ; Infant ; Infratentorial Neoplasms/classification ; Infratentorial Neoplasms/pathology ; Laminin/metabolism ; Male ; Neoplasm Grading ; Nerve Tissue Proteins/metabolism ; Survival Analysis ; Young Adult

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Enriched Bone Marrow Derived Disseminated Neuroblastoma Cells Can Be a Reliable Source for Gene Expression Studies-A Validation Study.
Autorzy:: Rifatbegovic F; CCRI, Children's Cancer Research Institute, St. Anna Kinderkrebsforschung, Vienna, Austria.
Abbasi MR; CCRI, Children's Cancer Research Institute, St. Anna Kinderkrebsforschung, Vienna, Austria.
Taschner-Mandl S; CCRI, Children's Cancer Research Institute, St. Anna Kinderkrebsforschung, Vienna, Austria.
Kauer M; CCRI, Children's Cancer Research Institute, St. Anna Kinderkrebsforschung, Vienna, Austria.
Weinhäusel A; Molecular Diagnostics, Health & Environment Department, AIT Austrian Institute of Technology GmbH, Vienna, Austria.
Handgretinger R; Children's University Hospital, University of Tuebingen, Tuebingen, Germany.
Ambros PF; CCRI, Children's Cancer Research Institute, St. Anna Kinderkrebsforschung, Vienna, Austria; Department of Pediatrics, Medical University of Vienna, Vienna, Austria.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2015 Sep 11; Vol. 10 (9), pp. e0137995. Date of Electronic Publication: 2015 Sep 11 (Print Publication: 2015).
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Gene Expression Profiling*
Gene Expression Regulation, Neoplastic*
Bone Marrow Neoplasms/*genetics
Bone Marrow Neoplasms/*secondary
Neuroblastoma/*genetics
Neuroblastoma/*pathology
Biomarkers, Tumor ; Cell Line, Tumor ; Cluster Analysis ; Humans ; Temperature ; Transcriptome

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Influence of segmental chromosome abnormalities on survival in children over the age of 12 months with unresectable localised peripheral neuroblastic tumours without MYCN amplification.
Autorzy:: Defferrari R; Department of Pathology, Istituto Giannina Gaslini, Genova 16148, Italy.
Mazzocco K; Department of Pathology, Istituto Giannina Gaslini, Genova 16148, Italy.
Ambros IM; Children's Cancer Research Institute, St Anna Kinderkrebsforschung, Vienna 1090, Austria.
Ambros PF; Children's Cancer Research Institute, St Anna Kinderkrebsforschung, Vienna 1090, Austria.
Bedwell C; Northern Genetics Service, Newcastle upon Tyne NEI 3 BZ, UK.
Beiske K; Department of Pathology, Oslo University Hospital Rikshopitalet, Oslo 0424, Norway.
Bénard J; Département de Biologie et de Pathologie Médicales, Gustave Roussy Cancer Campus, Villejuif 94800, France.
Berbegall AP; Department of Pathology, Medical School of Valencia, University of Valencia, Valencia 46010, Spain.
Bown N; Northern Genetics Service, Newcastle upon Tyne NEI 3 BZ, UK.
Combaret V; Laboratoire de Recherche Translationnelle, Centre Léon-Bérard, Lyon 69008, France.
Couturier J; Unité de Génétique Somatique et Cytogénétique, Institut Curie, Paris Cedex 05 75248, France.
Erminio G; Epidemiology, Biostatistics and Committees Unit, Istituto Giannina Gaslini, Genova 16148, Italy.
Gambini C; Department of Pathology, Istituto Giannina Gaslini, Genova 16148, Italy.
Garaventa A; Department of Haematology-Oncology, Istituto Giannina Gaslini, Genova 16148, Italy.
Gross N; Pediatric Oncology Research Unit, Lausanne University Hospital (CHUV), Lausanne 1011, Switzerland.
Haupt R; Epidemiology, Biostatistics and Committees Unit, Istituto Giannina Gaslini, Genova 16148, Italy.
Kohler J; Department of Paediatric Oncology, Southampton General Hospital, Southampton S016 6YD, UK.
Jeison M; Cancer Cytogenetique and Molecular Cytogenetique Laboratory, Schneider Children's Medical Center of Israel, Petah Tikva, Israel.
Lunec J; Northern Institute for Cancer Research, Newcastle University, Newcastle NE2 4HH, UK.
Marques B; Department of Human Genetics, National Institute of Health Doutor Ricardo Jorge, Lisbon 1649-016, Portugal.
Martinsson T; Department of Clinical Genetics, Göteborg University, Sahlgrenska University Hospital, Göteborg 413 45, Sweden.
Noguera R; Department of Pathology, Medical School of Valencia, University of Valencia, Valencia 46010, Spain.
Parodi S; Institute of Electronics, Computer and Telecommunication Engineering, National Research Council, Genova 16149, Italy.
Schleiermacher G; 1] INSERM U830, Laboratoire de Génétique et Biologie des Cancers, Paris Cedex 05 75248, France [2] Département d'Oncologie Pédiatrique, Institut Curie, Paris Cedex 05 75248, France.
Tweddle DA; Northern Institute for Cancer Research, Newcastle University, Newcastle NE2 4HH, UK.
Valent A; Département de Biologie et de Pathologie Médicales, Gustave Roussy Cancer Campus, Villejuif 94800, France.
Van Roy N; Center for Medical Genetics, Ghent University Hospital, Ghent 9000, Belgium.
Vicha A; Department of Paediatric Haematology and Oncology, Charles University and University Hospital Motol, Prague 15008, Czech Republic.
Villamon E; Department of Hematology, Hospital Universitari i Politècnic La Fe, Valencia 46009, Spain.
Tonini GP; Laboratory of Neuroblastoma, Onco/Haematology Laboratory, University of Padua, Pediatric Research Institute (IRP)-Città della Speranza, Corso Stati Uniti 4, Padova 35127, Italy.; Pokaż więcej
Źródło:: British journal of cancer [Br J Cancer] 2015 Jan 20; Vol. 112 (2), pp. 290-5. Date of Electronic Publication: 2014 Nov 04.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Neuroblastoma/*genetics
Peripheral Nervous System Neoplasms/*genetics
Chromosome Aberrations ; Comparative Genomic Hybridization ; Disease-Free Survival ; Gene Amplification ; Humans ; Infant ; Kaplan-Meier Estimate ; N-Myc Proto-Oncogene Protein ; Neuroblastoma/diagnosis ; Neuroblastoma/mortality ; Nuclear Proteins/genetics ; Oncogene Proteins/genetics ; Peripheral Nervous System Neoplasms/diagnosis ; Peripheral Nervous System Neoplasms/mortality ; Prognosis

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: Redirecting T cells to Ewing's sarcoma family of tumors by a chimeric NKG2D receptor expressed by lentiviral transduction or mRNA transfection.
Autorzy:: Lehner M; Laboratory of Cellular Therapy, Children's University Hospital, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany. />Götz G
Proff J
Schaft N
Dörrie J
Full F
Ensser A
Muller YA
Cerwenka A
Abken H
Parolini O
Ambros PF
Kovar H
Holter W; Pokaż więcej
Źródło:: PloS one [PLoS One] 2012; Vol. 7 (2), pp. e31210. Date of Electronic Publication: 2012 Feb 15.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Immunotherapy*
NK Cell Lectin-Like Receptor Subfamily K/*metabolism
RNA, Messenger/*administration & dosage
Recombinant Fusion Proteins/*metabolism
Sarcoma, Ewing/*immunology
Sarcoma, Ewing/*therapy
T-Lymphocytes/*immunology
Apoptosis ; Blotting, Western ; Cell Proliferation ; Enzyme-Linked Immunosorbent Assay ; Flow Cytometry ; Humans ; Lymphocyte Activation ; NK Cell Lectin-Like Receptor Subfamily K/genetics ; Recombinant Fusion Proteins/genetics ; T-Lymphocytes/transplantation ; Tumor Cells, Cultured

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: DNA damage, somatic aneuploidy, and malignant sarcoma susceptibility in muscular dystrophies.
Autorzy:: Schmidt WM; Neuromuscular Research Department, Center of Anatomy and Cell Biology, Medical University of Vienna, Vienna, Austria.
Uddin MH
Dysek S
Moser-Thier K
Pirker C
Höger H
Ambros IM
Ambros PF
Berger W
Bittner RE; Pokaż więcej
Źródło:: PLoS genetics [PLoS Genet] 2011 Apr; Vol. 7 (4), pp. e1002042. Date of Electronic Publication: 2011 Apr 14.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Aneuploidy*
DNA Damage*
Muscle, Skeletal/*pathology
Muscular Dystrophies/*genetics
Sarcoma/*genetics
Animals ; Calpain/genetics ; Calpain/metabolism ; Cells, Cultured ; Comparative Genomic Hybridization ; Disease Models, Animal ; Dysferlin ; Dystrophin/deficiency ; Dystrophin/genetics ; Dystrophin/metabolism ; Female ; Humans ; Membrane Proteins/genetics ; Membrane Proteins/metabolism ; Mice ; Mice, Inbred C57BL ; Models, Animal ; Muscle Proteins/genetics ; Muscle Proteins/metabolism ; Muscular Dystrophies/diagnosis ; Muscular Dystrophies/metabolism ; Mutation ; N-Acetylglucosaminyltransferases/genetics ; N-Acetylglucosaminyltransferases/metabolism

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee.
Autorzy:: Ambros PF; CCRI, Children's Cancer Research Institute, Vienna, Austria. ambros@ccri.at
Ambros IM
Brodeur GM
Haber M
Khan J
Nakagawara A
Schleiermacher G
Speleman F
Spitz R
London WB
Cohn SL
Pearson AD
Maris JM; Pokaż więcej
Źródło:: British journal of cancer [Br J Cancer] 2009 May 05; Vol. 100 (9), pp. 1471-82.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Neuroblastoma/*diagnosis
Neuroblastoma/*genetics
Chromosome Aberrations ; Chromosomes, Human, Pair 11 ; Chromosomes, Human, Pair 17 ; Consensus ; Gene Amplification ; Genetic Markers ; Humans ; International Cooperation ; N-Myc Proto-Oncogene Protein ; Neuroblastoma/epidemiology ; Neuroblastoma/psychology ; Neuroblastoma/therapy ; Nuclear Proteins/genetics ; Oncogene Proteins/genetics ; Patient Care Planning ; Ploidies ; Prognosis ; Protein Biosynthesis ; Risk Assessment ; Risk Factors ; Survival Analysis

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: Treatment of localised resectable neuroblastoma. Results of the LNESG1 study by the SIOP Europe Neuroblastoma Group.
Autorzy:: De Bernardi B; Department of Paediatric Haematology and Oncology, Giannina Gaslini Children's Hospital, Genova, Italy. />Mosseri V
Rubie H
Castel V
Foot A
Ladenstein R
Laureys G
Beck-Popovic M
de Lacerda AF
Pearson AD
De Kraker J
Ambros PF
de Rycke Y
Conte M
Bruzzi P
Michon J; Pokaż więcej
Corporate Authors:: SIOP Europe Neuroblastoma Group
Źródło:: British journal of cancer [Br J Cancer] 2008 Oct 07; Vol. 99 (7), pp. 1027-33. Date of Electronic Publication: 2008 Sep 02.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Neuroblastoma/*surgery
Disease Progression ; Disease-Free Survival ; Europe ; Female ; Genes, myc ; Humans ; Infant ; Infant, Newborn ; Male ; Neuroblastoma/genetics ; Prognosis ; Recurrence ; Survival Rate

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: FKHRL1-mediated expression of Noxa and Bim induces apoptosis via the mitochondria in neuroblastoma cells.
Autorzy:: Obexer P; Tyrolean Cancer Research Institute, Innsbruck, Austria. />Geiger K
Ambros PF
Meister B
Ausserlechner MJ; Pokaż więcej
Źródło:: Cell death and differentiation [Cell Death Differ] 2007 Mar; Vol. 14 (3), pp. 534-47. Date of Electronic Publication: 2006 Aug 04.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Gene Expression Regulation, Neoplastic*
Apoptosis Regulatory Proteins/*metabolism
Forkhead Transcription Factors/*metabolism
Membrane Proteins/*metabolism
Mitochondria/*metabolism
Neuroblastoma/*metabolism
Proto-Oncogene Proteins/*metabolism
Proto-Oncogene Proteins c-bcl-2/*metabolism
3-Phosphoinositide-Dependent Protein Kinases ; Apoptosis ; Apoptosis Regulatory Proteins/genetics ; Bcl-2-Like Protein 11 ; Caspases/metabolism ; Cell Death ; Fas-Associated Death Domain Protein/metabolism ; Fas-Associated Death Domain Protein/physiology ; Forkhead Box Protein O3 ; Forkhead Transcription Factors/genetics ; Humans ; Membrane Proteins/genetics ; Models, Biological ; Peptide Fragments/metabolism ; Phosphatidylinositol 3-Kinases/metabolism ; Protein Serine-Threonine Kinases/metabolism ; Proto-Oncogene Proteins/genetics ; Proto-Oncogene Proteins c-bcl-2/genetics ; Receptors, TNF-Related Apoptosis-Inducing Ligand/metabolism ; Reverse Transcriptase Polymerase Chain Reaction ; Signal Transduction ; TNF-Related Apoptosis-Inducing Ligand/metabolism ; Tamoxifen/analysis ; Tamoxifen/pharmacology ; Transduction, Genetic ; fas Receptor/metabolism ; fas Receptor/physiology

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: Prognostic impact of chromosomal aberrations in Ewing tumours.
Autorzy:: Hattinger CM; CCRI, St. Anna Children's Hospital, A-1090 Vienna, Austria. />Pötschger U
Tarkkanen M
Squire J
Zielenska M
Kiuru-Kuhlefelt S
Kager L
Thorner P
Knuutila S
Niggli FK
Ambros PF
Gadner H
Betts DR; Pokaż więcej
Źródło:: British journal of cancer [Br J Cancer] 2002 Jun 05; Vol. 86 (11), pp. 1763-9.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Chromosome Aberrations*
Chromosome Mapping*
Bone Neoplasms/*genetics
Sarcoma, Ewing/*genetics
Adult ; Age Factors ; Aged ; Bone Neoplasms/mortality ; Female ; Humans ; Male ; Middle Aged ; Predictive Value of Tests ; Prognosis ; Sarcoma, Ewing/mortality ; Sex Characteristics ; Survival Rate

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: Unequivocal identification of disseminated tumor cells in the bone marrow by combining immunological and genetic approaches--functional and prognostic information.
Autorzy:: Ambros PF; CCRI, St Anna Kinderspital, Vienna, Austria.
Méhes G
Hattinger C
Ambros IM
Luegmayr A
Ladenstein R
Gadner H; Pokaż więcej
Źródło:: Leukemia [Leukemia] 2001 Feb; Vol. 15 (2), pp. 275-7.
Typ publikacji:: Journal Article
MeSH Terms:: Bone Marrow/*pathology
Neoplasms/*pathology
Flow Cytometry ; Fluorescent Antibody Technique ; Humans ; Neoplasms/genetics ; Neoplasms/immunology ; Reverse Transcriptase Polymerase Chain Reaction